Acquisition of an existing facility is speedier, but at times, has its own challenges, such as past liabilities, obsolete equipment, and labour issues. It entails a recalibration of transfer pricing policies, meeting Fema rules on outbound investments, and following local business, labour, and green laws. "Cross-border realignments bring into play complex international tax issues, indirect tax exposure on inter-company flows, and potential scrutiny of profit allocation across various operations. It currently has a manufacturing facility in Palatine, Illinois. Piramal Pharma will invest $90 million to expand its two US facilities -Lexington in Kentucky and Riverview in Michigan-to meet the growing demand.

Source: The Times August 21, 2025 02:54 UTC